Champions Oncology ( NASDAQ:CSBR ) Third Quarter 2025 Results Key Financial Results Revenue: US$17.0m (up 42% from 3Q... HACKENSACK, NJ / ACCESS Newswire / March 11, 2025 / Champions Oncology ...
Hosted on MSN2mon
CSBR stock hits 52-week high at $10.91 amid robust growthChampions Oncology , Inc. (NASDAQ:CSBR) stock soared to a 52-week high, reaching $10.91, marking a significant milestone for the company specializing in advanced technology solutions and services ...
We have seen 10 institutional investors add shares of $CSBR stock to their portfolio, and 8 decrease their positions in their most recent quarter.
As of 2:16:08 PM EDT. Market Open. HACKENSACK, NJ / ACCESS Newswire / March 11, 2025 / Champions Oncology, Inc. (Nasdaq:CSBR), a global preclinical and clinical research services provider that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback